Figure 1 | Scientific Reports

Figure 1

From: Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial

Figure 1

Randomization, treatment assignments, and follow-up. The figure shows that patients were recruited through May 31, 2022, to July 24, 2022, from two alternate care sites in Shanghai, China, and underwent stratified randomization according to de novo infection or viral rebound of SARS-CoV-2. Treatment assignments and follow-up were conducted.

Back to article page